公开(公告)号：US20240358964A1

公开(公告)日：2024-10-31

申请号：US18681850

申请日：2022-08-04

申请人： Hollister Incorporated

发明人： Patrick John Doherty

IPC分类号： A61M25/00

CPC分类号： A61M25/0017 ,  A61M25/002 ,  A61M25/0045

摘要： An intermittent urinary catheter product includes a generally rectangular package (100) having opposed front (104) and rear (106) panels sealed together to define an interior cavity (103). At least one of an inner surface (105) of the front panel (104) and an inner surface (107) of the rear panel (106) includes a reclosable member (116) associated therewith. The front and rear panels are tearable adjacent to the reclosable member and in a direction parallel to the reclosable member so that the tear forms an opening (120) in communication with the interior cavity. A hydrophilic urinary catheter (123) and hydration fluid (140) may be stored in the package. After a user uses the catheter, the user may replace the catheter in the cavity and close the reclosable member, resealing the package.

公开(公告)号：US20240358943A1

公开(公告)日：2024-10-31

申请号：US18643017

申请日：2024-04-23

申请人： Loewenstein Medical Technology S.A.

发明人： Angela GERLACH

IPC分类号： A61M16/00

CPC分类号： A61M16/0066 ,  A61M2205/10 ,  A61M2205/42

摘要： A ventilator comprising an inlet, an outlet and a blower, wherein the ventilator forms, between the inlet and the outlet, a respiratory gas path which is routed through the blower. The ventilator, for the routing of the respiratory gas path, further comprises a chamber, a first channel leading into the chamber, and a second channel leading into the chamber. A first acoustic impedance of the first channel and a second acoustic impedance of the second channel deviate from a third acoustic impedance of the chamber such that a sound generated by the blower is attenuated.

公开(公告)号：US20240358936A1

公开(公告)日：2024-10-31

申请号：US18770650

申请日：2024-07-12

申请人： WUXI NEST BIOTECHNOLOGY CO., LTD

发明人： Feng CHEN ,  Weidong YANG

IPC分类号： A61M11/00

CPC分类号： A61M11/007 ,  A61M2210/0618

摘要： The present disclosure discloses an atomizing nozzle and a nasal drug delivery device. The atomizing nozzle includes a spray hood which includes a conical hood body and a connecting cylinder provided inside the hood body and connected to the inner top of the hood body, the wall of the connecting cylinder is provided with a bayonet structure or a claw structure for non-detachable snap fit with the corresponding claw structure or the bayonet structure on the outer side of the syringe extending into the connecting cylinder, a columnar end extends from the external tip of the hood body for extending into the internal nasal cavity, the connecting cylinder, the columnar end and a portion of the hood body therebetween jointly form a communicating channel, the front end of the columnar end is provided with a spray hole, and a fluid-guiding cylinder.

公开(公告)号：US20240358927A1

公开(公告)日：2024-10-31

申请号：US18647377

申请日：2024-04-26

申请人： Boston Scientific Medical Device Limited ,  Boston Scientific Scimed, Inc.

发明人： Nitesh Ghananil Baviskar ,  Benjamin Cleveland ,  Sanjay Kumar Chandra ,  Katie Knowles ,  Junaid Mohammed Shaikh ,  Marshall O'Hearn

IPC分类号： A61M5/28 ,  A61M5/315 ,  A61M5/32

CPC分类号： A61M5/284 ,  A61M5/31511 ,  A61M5/3202

摘要： Mixing systems for producing a mixture to deliver to a treatment site. An illustrative system may comprise a needle hub, a multi-reservoir system, and a syringe. The multi-reservoir system may comprise a plunger assembly including a first plunger and a second plunger, a barrel portion including a housing defining a first reservoir in fluid communication with a first port and configured to contain a first constituent and a second reservoir configured to contain a second constituent and in fluid communication with a second port, and a cap including a port and a lumen extending therethrough. A third constituent may be injected from the syringe into the first reservoir via the port of the cap to form a precursor. Actuating the plunger assembly relative to the barrel portion may cause the precursor and the second constituent to be delivered into the needle hub.

公开(公告)号：US20240358926A1

公开(公告)日：2024-10-31

申请号：US18293981

申请日：2022-08-03

申请人： SHL Medical AG

发明人： Ming-Ting Yin ,  Philipp Zingel ,  Roman Käslin ,  Lino Manuel Heckhorn Ghilardi

IPC分类号： A61M5/28 ,  A61M5/32

CPC分类号： A61M5/281 ,  A61M5/3243 ,  A61M2207/10

摘要： An expulsion assembly (100) of a medicament delivery device (102) for expelling medicament from a medicament container structure (250), the expulsion assembly comprising a container holder (125) having a container proximal end (212) and a container distal end (214), the container holder being configured to house the medicament container structure, and an axially extending needle cover (123), the needle cover having a needle cover proximal end (202) comprising a tubular shaped needle cover portion (206), and a needle cover distal end (204), wherein the container holder is at least partly enclosed by the needle cover, wherein a portion (121) of the outer surface of the container holder (125) and a portion (129) of the needle cover form an interface section (127) comprising an axially extending groove (220) and a protrusion (222) in which the container holder and the needle cover are arranged in abutment with each other.

公开(公告)号：US20240358923A1

公开(公告)日：2024-10-31

申请号：US18658491

申请日：2024-05-08

申请人： Pirouette Medical Inc.

发明人： Elijah KAPAS ,  Matthew KANE ,  Conor CULLINANE

IPC分类号： A61M5/20 ,  A61M5/142 ,  A61M5/24 ,  A61M5/315 ,  A61M5/32 ,  A61M5/46

CPC分类号： A61M5/2033 ,  A61M5/14244 ,  A61M5/14248 ,  A61M5/20 ,  A61M5/46 ,  A61M2005/14284 ,  A61M2005/206 ,  A61M2005/2073 ,  A61M5/24 ,  A61M5/2466 ,  A61M2005/2474 ,  A61M5/31565 ,  A61M5/31571 ,  A61M5/3158 ,  A61M5/3202 ,  A61M5/3232

摘要： A novel single use auto-injector for delivering a fixed amount of medicament is described. The auto-injector may include a sealed housing rotatably held in a cover. Once the auto-injector is positioned at the injection location, the user can transition the housing from a locked to an armed position. The user can then compress the sealed housing into the cover, triggering activation mechanisms that initiate the injection. A first activation mechanism engages an interlock to prevent reuse of the auto-injector. A second activation mechanism straightens and extends a curved needle to a set the exposed needle length. A third activation mechanism pierces a sealed reservoir allowing the medicament to be forced through the injection needle. Following the injection, the auto-injector expands and interlocks, retracting the needle into the auto-injector and preventing reuse.

公开(公告)号：US20240358922A1

公开(公告)日：2024-10-31

申请号：US18646387

申请日：2024-04-25

申请人： Boston Scientific Medical Device Limited ,  Boston Scientific Scimed, Inc.

发明人： Nitesh Ghananil Baviskar ,  Benjamin Cleveland ,  Sanjay Kumar Chandra ,  Katie Knowles ,  Junaid Mohammed Shaikh ,  Marshall O'Hearn ,  Rohit Bhardwaj

IPC分类号： A61M5/19 ,  A61M5/31 ,  A61M5/315 ,  A61M5/32

CPC分类号： A61M5/19 ,  A61M5/3129 ,  A61M5/31511 ,  A61M5/32 ,  A61M2005/31598

摘要： Mixing systems for producing a mixture to deliver to a treatment site. An illustrative system may comprise a needle hub and a multi-reservoir system including a plunger assembly and a barrel portion. The barrel portion may include a first lumen, a second lumen, and a plurality of channels formed in a wall of the first lumen. A first movable gasket may divide the first lumen into a first reservoir configured to contain a first constituent and a second reservoir configured to contain a second constituent. A second gasket may bound a third reservoir configured to contain a third constituent. Actuating the plunger assembly relative to the barrel portion may first cause the diluent to be injected into the second reservoir to form a precursor and then cause the precursor and the second constituent to be delivered into the needle hub.

公开(公告)号：US20240358919A1

公开(公告)日：2024-10-31

申请号：US18764688

申请日：2024-07-05

申请人： Abbott Diabetes Care Inc.

发明人： Erwin S. BUDIMAN ,  Gary A. HAYTER ,  Nathan C. CROUTHER ,  Marc B. TAUB ,  Wesley Scott HARPER ,  Charles WEI

IPC分类号： A61M5/172 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1495 ,  A61M5/142 ,  G16H20/17

CPC分类号： A61M5/1723 ,  A61B5/14532 ,  A61B5/1495 ,  A61B5/4839 ,  G16H20/17 ,  A61B2562/0295 ,  A61M2005/14208 ,  A61M2005/14296 ,  A61M2205/3569 ,  A61M2205/52 ,  A61M2230/201

摘要： Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.

公开(公告)号：US20240358918A1

公开(公告)日：2024-10-31

申请号：US18291717

申请日：2022-07-28

申请人： SHL Medical AG

发明人： Martin Michael Coyne, III ,  Christopher James Franzese ,  Molly Christine Larson-Wakeman ,  Alejandra Linares Martinez ,  Matthew Conner D'Auria ,  Katherine Ford Brigham ,  Sebastian Karlsson ,  Christoph Egloff ,  Madeleine Hayden Anderson

IPC分类号： A61M5/168 ,  A61M5/158 ,  A61M5/172 ,  A61M39/08

CPC分类号： A61M5/16804 ,  A61M5/158 ,  A61M5/1723 ,  A61M39/08 ,  A61M2039/082 ,  A61M2205/0233 ,  A61M2205/3334 ,  A61M2205/587

摘要： Apparatus including tubing sets and methods of use are described for deliver a therapeutic medication to a patient, the apparatus comprising a controller and a sensor. The controller is configured to receive data from the sensor, and to start and stop delivery of the therapeutic medication to the patient in response to data received from the sensor. In addition, apparatus, systems and methods are disclosed, which are configured to deliver a therapeutic medication to a patient. The apparatus, system and methods comprise a reservoir, a patient interface, a tubing set, and a fluid pump, and the components are configured to provide a calibrated flow rate based upon specific characteristics of the therapeutic medications passing through and internal lumen of the tubing set.

公开(公告)号：US20240358913A1

公开(公告)日：2024-10-31

申请号：US18764514

申请日：2024-07-05

申请人： Kimberley Levy ,  Frank Levy

发明人： Kimberley Levy ,  Frank Levy

IPC分类号： A61M5/00 ,  A61M5/178 ,  A61M5/19 ,  A61M39/00 ,  A61M39/22 ,  A61M39/24

CPC分类号： A61M5/007 ,  A61M5/19 ,  A61M39/223 ,  A61M2005/006 ,  A61M2005/1787 ,  A61M2039/0009 ,  A61M2039/0027 ,  A61M39/24 ,  A61M2202/0225 ,  F04C2270/0421

摘要： A system for controlled delivery of medical fluids to a patient includes an inlet conduit attached to a source of a medical fluid and an outlet conduit connected to the patient. The inlet and outlet conduits are interconnected by a multiple stage control valve assembly and a pair of syringes. The control valve assembly is alternated between a first state wherein the inlet conduit communicates with a first syringe for transmitting fluid from the source to the first syringe, a second state wherein the first syringe communicates with a second syringe and is isolated from the inlet conduit and the outlet for transmitting fluid from the first syringe to the second syringe, and a third state wherein the second syringe communicates with the outlet and is isolated from the inlet and the first syringe for transmitting fluid from the second syringe to the patient through the outlet.